BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soriano-Ursúa MA, Das BC, Trujillo-Ferrara JG. Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy. Expert Opin Ther Pat. 2014;24:485-500. [PMID: 24456081 DOI: 10.1517/13543776.2014.881472] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Chellan P, Sadler PJ. The elements of life and medicines. Philos Trans A Math Phys Eng Sci 2015;373:20140182. [PMID: 25666066 DOI: 10.1098/rsta.2014.0182] [Cited by in Crossref: 103] [Cited by in F6Publishing: 51] [Article Influence: 17.2] [Reference Citation Analysis]
2 Chaari M, Kelemen Z, Choquesillo-lazarte D, Gaztelumendi N, Teixidor F, Viñas C, Nogués C, Núñez R. Efficient blue light emitting materials based on m -carborane–anthracene dyads. Structure, photophysics and bioimaging studies. Biomater Sci 2019;7:5324-37. [DOI: 10.1039/c9bm00903e] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Bolt HM, Duydu Y, Başaran N, Golka K. Boron and its compounds: current biological research activities. Arch Toxicol 2017;91:2719-22. [PMID: 28601966 DOI: 10.1007/s00204-017-2010-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
4 Soriano-Ursúa MA, Arias-Montaño JA, Correa-Basurto J, Hernández-Martínez CF, López-Cabrera Y, Castillo-Hernández MC, Padilla-Martínez II, Trujillo-Ferrara JG. Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the β2 adrenoceptor. Bioorg Med Chem Lett 2015;25:820-5. [PMID: 25592716 DOI: 10.1016/j.bmcl.2014.12.077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Soriano-ursúa MA, Farfán-garcía ED, Geninatti-crich S. Turning Fear of Boron Toxicity into Boron-containing Drug Design. CMC 2019;26:5005-18. [DOI: 10.2174/0929867326666190327154954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
6 Donoiu I, Militaru C, Obleagă O, Hunter JM, Neamţu J, Biţă A, Scorei IR, Rogoveanu OC. Effects of boron-containing compounds on cardiovascular disease risk factors – A review. Journal of Trace Elements in Medicine and Biology 2018;50:47-56. [DOI: 10.1016/j.jtemb.2018.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
7 Galliamova LA, Varaksin MV, Chupakhin ON, Slepukhin PA, Charushin VN. Heterocyclic and Open-Chain Carboranes via Transition-Metal-Free C–H Functionalization of Mono- and Diazine- N -oxides. Organometallics 2015;34:5285-90. [DOI: 10.1021/acs.organomet.5b00736] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
8 Reddy ER, Trivedi R, Sarma AVS, Sridhar B, Anantaraju HS, Sriram D, Yogeeswari P, Nagesh N. Sugar-boronate ester scaffold tethered pyridyl-imine palladium( ii ) complexes: synthesis and their in vitro anticancer evaluation. Dalton Trans 2015;44:17600-16. [DOI: 10.1039/c5dt03266k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 Morera E, Di Marzo V, Monti L, Allarà M, Schiano Moriello A, Nalli M, Ortar G, De Petrocellis L. Arylboronic acids as dual-action FAAH and TRPV1 ligands. Bioorg Med Chem Lett 2016;26:1401-5. [PMID: 26850005 DOI: 10.1016/j.bmcl.2016.01.071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bello M, Guadarrama-García C, Velasco-Silveyra LM, Farfán-García ED, Soriano-Ursúa MA. Several effects of boron are induced by uncoupling steroid hormones from their transporters in blood. Med Hypotheses 2018;118:78-83. [PMID: 30037620 DOI: 10.1016/j.mehy.2018.06.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
11 López-cabrera Y, Castillo-garcía EL, Altamirano-espino JA, Pérez-capistran T, Farfán-garcía ED, Trujillo-ferrara JG, Soriano-ursúa MA. Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats. Journal of Trace Elements in Medicine and Biology 2018;50:424-9. [DOI: 10.1016/j.jtemb.2018.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
12 Barry NP, Pitto-Barry A, Romero-Canelón I, Tran J, Soldevila-Barreda JJ, Hands-Portman I, Smith CJ, Kirby N, Dove AP, O'Reilly RK, Sadler PJ. Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity. Faraday Discuss 2014;175:229-40. [PMID: 25270092 DOI: 10.1039/c4fd00098f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
13 Ritacca AG, Ritacco I, Dabbish E, Russo N, Mazzone G, Sicilia E. A Boron-Containing Compound Acting on Multiple Targets Against Alzheimer's Disease. Insights from Ab Initio and Molecular Dynamics Simulations. J Chem Inf Model 2021;61:3397-410. [PMID: 34253017 DOI: 10.1021/acs.jcim.1c00262] [Reference Citation Analysis]
14 Labra‐vázquez P, Flores‐cruz R, Galindo‐hernández A, Cabrera‐gonzález J, Guzmán‐cedillo C, Jiménez‐sánchez A, Lacroix PG, Santillan R, Farfán N, Núñez R. Tuning the Cell Uptake and Subcellular Distribution in BODIPY–Carboranyl Dyads: An Experimental and Theoretical Study. Chem Eur J 2020;26:16530-40. [DOI: 10.1002/chem.202002600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
15 Mehrabi T, Mesgar AS, Mohammadi Z. Bioactive Glasses: A Promising Therapeutic Ion Release Strategy for Enhancing Wound Healing. ACS Biomater Sci Eng 2020;6:5399-430. [PMID: 33320556 DOI: 10.1021/acsbiomaterials.0c00528] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
16 Jankowska A, Świerczek A, Wyska E, Gawalska A, Bucki A, Pawłowski M, Chłoń-Rzepa G. Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research. Curr Drug Targets 2019;20:122-43. [PMID: 30091414 DOI: 10.2174/1389450119666180808105056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
17 Hunter JM, Nemzer BV, Rangavajla N, Biţă A, Rogoveanu OC, Neamţu J, Scorei IR, Bejenaru LE, Rău G, Bejenaru C, Mogoşanu GD. The Fructoborates: Part of a Family of Naturally Occurring Sugar-Borate Complexes-Biochemistry, Physiology, and Impact on Human Health: a Review. Biol Trace Elem Res 2019;188:11-25. [PMID: 30343480 DOI: 10.1007/s12011-018-1550-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
18 Jinna S, Finch J. Spotlight on tavaborole for the treatment of onychomycosis. Drug Des Devel Ther 2015;9:6185-90. [PMID: 26640371 DOI: 10.2147/DDDT.S81944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
19 Bellomo C, Chaari M, Cabrera‐gonzález J, Blangetti M, Lombardi C, Deagostino A, Viñas C, Gaztelumendi N, Nogués C, Nuñez R, Prandi C. Carborane‐BODIPY Dyads: New Photoluminescent Materials through an Efficient Heck Coupling. Chem Eur J 2018;24:15622-30. [DOI: 10.1002/chem.201802901] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
20 Pérez-rodríguez M, García-mendoza E, Farfán-garcía ED, Das BC, Ciprés-flores FJ, Trujillo-ferrara JG, Tamay-cach F, Soriano-ursúa MA. Not all boronic acids with a five-membered cycle induce tremor, neuronal damage and decreased dopamine. NeuroToxicology 2017;62:92-9. [DOI: 10.1016/j.neuro.2017.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Haverić A, Durmić-Pašić A, Alić A, Mujezinović I, Smajlović A, Ostojić J, Ahatović A, Hadžić M, Prašović S, Haverić S, Galić B. Biochemical and histomorphological findings in Swiss Wistar rats treated with potential boron-containing therapeutic - K2[B3O3F4OH]. J Trace Elem Med Biol 2020;62:126642. [PMID: 32950859 DOI: 10.1016/j.jtemb.2020.126642] [Reference Citation Analysis]
22 Yang F, Zhu M, Zhang J, Zhou H. Synthesis of biologically active boron-containing compounds. Medchemcomm 2018;9:201-11. [PMID: 30108914 DOI: 10.1039/c7md00552k] [Cited by in Crossref: 53] [Cited by in F6Publishing: 6] [Article Influence: 13.3] [Reference Citation Analysis]
23 Ou M, Wang X, Yu L, Liu C, Tao W, Ji X, Mei L. The Emergence and Evolution of Borophene. Adv Sci (Weinh) 2021;8:2001801. [PMID: 34194924 DOI: 10.1002/advs.202001801] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Behnam MAM, Sundermann TR, Klein CD. Solid Phase Synthesis of C-Terminal Boronic Acid Peptides. Org Lett 2016;18:2016-9. [DOI: 10.1021/acs.orglett.6b00625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Romero-Aguilar KS, Arciniega-Martínez IM, Farfán-García ED, Campos-Rodríguez R, Reséndiz-Albor AA, Soriano-Ursúa MA. Effects of boron-containing compounds on immune responses: review and patenting trends. Expert Opin Ther Pat 2019;29:339-51. [PMID: 31064237 DOI: 10.1080/13543776.2019.1612368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
26 Patterson AE, Flewelling AJ, Clark TN, Geier SJ, Vogels CM, Masuda JD, Gray CA, Westcott SA. Antimicrobial and antimycobacterial activities of aliphatic amines derived from vanillin. Can J Chem 2015;93:1305-11. [DOI: 10.1139/cjc-2015-0400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 G Sangu K, U Shinde A, Chopra S, B Rode H. Evading antimicrobial resistance using boron-containing therapeutics. Future Med Chem 2021;13:229-32. [PMID: 33275037 DOI: 10.4155/fmc-2020-0161] [Reference Citation Analysis]
28 Ocampo-Néstor AL, Trujillo-Ferrara JG, Abad-García A, Reyes-López C, Geninatti-Crich S, Soriano-Ursúa MA. Boron's journey: advances in the study and application of pharmacokinetics. Expert Opin Ther Pat 2017;27:203-15. [PMID: 27788608 DOI: 10.1080/13543776.2017.1252750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
29 Farfán-García ED, Castillo-Mendieta NT, Ciprés-Flores FJ, Padilla-Martínez II, Trujillo-Ferrara JG, Soriano-Ursúa MA. Current data regarding the structure-toxicity relationship of boron-containing compounds. Toxicol Lett 2016;258:115-25. [PMID: 27329537 DOI: 10.1016/j.toxlet.2016.06.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]